Clinical Trial Update: Bevacizumab w / Temozolomide PET & Vascular MRI For GBM [NA]

View source ↗

Summary

Clinical trial update for bevacizumab with temozolomide and PET/vascular MRI in recurrent glioblastoma; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Recurrent Glioblastoma | NA | Status: COMPLETED | Results posted: 2020-09-04